反芻動物用ワクチンの世界市場レポート 2025年

反芻動物用ワクチン市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.7％で、41億3,000万米ドルに成長します。予測期間の成長は、研究開発への投資拡大、動物病院やクリニックの拡張と近代化、食肉と乳製品の消費拡大、動物の予防ヘルスケアへの注目の高まり、家畜貿易の世界化に起因しています。予測期間における主な動向としては、組み換えワクチンやデオキシリボ核酸（DNA）ワクチンの採用、自家ワクチン使用の革新、耐熱性ワクチンの開発への注力、ワクチン開発における人工知能の統合、ワクチン送達におけるナノテクノロジーの利用などが挙げられます。

畜産物に対する需要の高まりが、今後の反芻動物用ワクチン市場の拡大を牽引すると予想されます。畜産品には、肉、牛乳、卵、羊毛、皮革、ゼラチンや動物性脂肪などの製品別など、家畜に由来する商品が含まれます。畜産物の需要に寄与する要因としては、食生活の嗜好の変化、消費者のアクセスの増加、手ごろな価格、経済成長、ライフスタイルの変化などが挙げられます。反芻動物用ワクチンは、家畜の健康状態を改善し、疾病の発生を予防し、生産性を高め、飼料効率を向上させ、肉、ミルク、その他の製品別の安定的かつ持続可能な供給を確保することにより、畜産を促進する上で重要な役割を果たしています。たとえば2024年2月、英国の政府機関である環境・食料・農村地域省の報告書によると、2022年の畜産総生産高は250億5,000万米ドルに達し、2021年比で35億米ドル（16%）の増加を記録しました。このように、畜産物に対する需要の高まりが反芻動物用ワクチン市場の成長を牽引しています。

反芻動物用ワクチン市場の主なプレーヤーは、青舌ウイルス（BTV）血清型3ワクチンなど、このウイルスに対する効果的な防御を提供する先進製品の開発に注力しています。BTV血清型3ワクチンは、牛や羊などの反芻動物の青舌病を予防するために設計されています。例えば、2024年5月、ドイツを拠点とするバイオ医薬品会社ベーリンガー・インゲルハイム・インターナショナルGmbHは、反芻動物用ワクチンのラインナップにBultavo 3を導入しました。この不活化ワクチンはブルータング・ウイルスの血清型3に対する予防効果があり、ウイルスの循環、死亡率、臨床症状を大幅に減少させる。このワクチンの発売は、最近のアウトブレイクによるBTV-3ワクチンの緊急の必要性に対応するもので、家畜の健康を守り、農家の経済的損失を軽減するのに役立ちます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界反芻動物用ワクチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の反芻動物用ワクチン市場：成長率分析
• 世界の反芻動物用ワクチン市場の実績：規模と成長, 2019-2024
• 世界の反芻動物用ワクチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界反芻動物用ワクチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の反芻動物用ワクチン市場ワクチンの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ワクチン
• 弱毒化生ワクチンまたは改変生ワクチン
• その他のワクチンの種類
• 世界の反芻動物用ワクチン市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛呼吸器疾患（BRD）
• 下痢または下痢
• 口蹄疫（FMD）
• クロストリジウム感染症
• レプトスピラ症
• 牛ウイルス性下痢症（BVD）感染症
• その他の適応症
• 世界の反芻動物用ワクチン市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 筋肉内
• 皮下
• 鼻腔内
• オーラル
• 世界の反芻動物用ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛
• 羊
• その他の用途
• 世界の反芻動物用ワクチン市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院とクリニック
• 畜産農場
• 調査機関
• 世界の反芻動物用ワクチン市場不活化ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 不活化ウイルスワクチン
• 細菌不活化ワクチン
• サブユニットワクチン
• 世界の反芻動物用ワクチン市場弱毒化生ワクチンまたは改変生ワクチンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生弱毒化ウイルスワクチン
• 生細菌ワクチン
• 組換え生ワクチン
• 世界の反芻動物用ワクチン市場、その他のワクチンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• DNAワクチン
• mRNAワクチン
• ウイルスベクターワクチン

第7章 地域別・国別分析

• 世界の反芻動物用ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の反芻動物用ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 反芻動物用ワクチン市場：競合情勢
• 反芻動物用ワクチン市場：企業プロファイル
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Virbac
• Phibro Animal Health Corporation
• Vetoquinol S.A.
• Indian Immunologicals Ltd.
• Anicon Labor GmbH（SAN Group）
• IDT Biologika GmbH
• Jinyu Bio-Technology Co. Ltd.
• Vaxxinova International B.V.
• Biogenesis Bago S.A
• CZ Vaccines
• Hester Biosciences Limited
• Choong Ang Vaccine Laboratories Co. Ltd.
• Hipra Corporations
• VETVACO National Veterinary Joint Stock Company
• Kyoto Biken Laboratories Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 反芻動物用ワクチン市場2029：新たな機会を提供する国
• 反芻動物用ワクチン市場2029：新たな機会を提供するセグメント
• 反芻動物用ワクチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Ruminant vaccines are designed to safeguard ruminant animals from a range of infectious diseases. Ruminants, which include animals with a four-compartment stomach (rumen, reticulum, omasum, and abomasum), are herbivores that process fibrous plant material. These vaccines are crucial for maintaining the health, productivity, and welfare of ruminants by preventing diseases such as foot-and-mouth disease, brucellosis, bovine respiratory disease, and clostridial infections.

The primary types of ruminant vaccines include inactivated vaccines, attenuated or modified live vaccines, and others. Inactivated vaccines consist of pathogens that have been killed or inactivated, which helps to elicit an immune response without causing disease. These vaccines are used to protect against various conditions such as bovine respiratory diseases (BRD), diarrhea or scours, foot-and-mouth disease (FMD), clostridial diseases, leptospirosis, and bovine viral diarrhea (BVD) infection. They can be administered via intramuscular, subcutaneous, intranasal, or oral routes. Ruminant vaccines are used for cattle, sheep, and other ruminants, and are typically provided to veterinary hospitals and clinics, livestock farms, and research institutes.

The ruminant vaccines market research report is one of a series of new reports from The Business Research Company that provides ruminant vaccines market statistics, including ruminant vaccines industry global market size, regional shares, competitors with a ruminant vaccines market share, detailed ruminant vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the ruminant vaccines industry. This ruminant vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ruminant vaccines market size has grown strongly in recent years. It will grow from $2.98 billion in 2024 to $3.19 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to increasing livestock populations, rising prevalence of zoonotic diseases, government initiatives for disease eradication, growing demand for animal protein, and increasing awareness about animal health.

The ruminant vaccines market size is expected to see strong growth in the next few years. It will grow to $4.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to growing investments in research and development, expansion and modernization of veterinary clinics and hospitals, growing consumption of meat and dairy products, increasing focus on preventive healthcare in animals, and globalization of livestock trade. Major trends in the forecast period include adoption of recombinant and deoxyribonucleic acid (DNA) vaccines, innovation in autogenous vaccine usage, focus on developing thermostable vaccines, integration of artificial intelligence in vaccine development, and use of nanotechnology in vaccine delivery.

The growing demand for livestock products is anticipated to drive the expansion of the ruminant vaccines market in the future. Livestock products include goods derived from domesticated animals, such as meat, milk, eggs, wool, leather, and by-products like gelatin and animal fats. Factors contributing to the demand for these products include shifting dietary preferences, increased consumer access, greater affordability, economic growth, and changing lifestyle patterns. Ruminant vaccines play a crucial role in boosting livestock production by improving animal health, preventing disease outbreaks, enhancing productivity, increasing feed efficiency, and ensuring a stable and sustainable supply of meat, milk, and other by-products. For instance, in February 2024, a report from the Department for Environment, Food and Rural Affairs, a UK-based government agency, noted that the total livestock output in 2022 reached $25.05 billion, marking an increase of $3.50 billion (16%) compared to 2021. Thus, the rising demand for livestock products is driving the growth of the ruminant vaccines market.

Key players in the ruminant vaccines market are focusing on developing advanced products such as the bluetongue virus (BTV) serotype 3 vaccine, which provides effective protection against this virus. The BTV serotype 3 vaccine is designed to prevent bluetongue disease in ruminants such as cattle and sheep. For instance, in May 2024, Boehringer Ingelheim International GmbH, a Germany-based biopharmaceutical company, introduced Bultavo 3 to its ruminant vaccine lineup. This inactivated vaccine offers protection against bluetongue virus serotype 3, significantly reducing virus circulation, mortality, and clinical signs. Its launch addresses the urgent need for a BTV-3 vaccine due to recent outbreaks, helping to safeguard livestock health and reduce economic losses for farmers.

In April 2024, Virbac Group, a France-based animal health products manufacturer, acquired Sasaeah Pharmaceutical Co. Ltd. for an undisclosed amount. This acquisition aims to strengthen Virbac's position in the Japanese livestock vaccine market, particularly for cattle, by leveraging Sasaeah's established production facilities, extensive R&D capabilities, and broad pharmaceutical portfolio. This move supports Virbac's strategic growth and expansion in the animal health sector. Sasaeah Pharmaceutical Co. Ltd., based in Japan, specializes in manufacturing ruminant vaccines.

Major companies operating in the ruminant vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc., Merck & Co. Inc., Elanco Animal Health Inc., Ceva Sante Animale, Virbac, Phibro Animal Health Corporation, Vetoquinol S.A., Indian Immunologicals Ltd., Anicon Labor GmbH (SAN Group), IDT Biologika GmbH, Jinyu Bio-Technology Co. Ltd., Vaxxinova International B.V., Biogenesis Bago S.A, CZ Vaccines, Hester Biosciences Limited, Choong Ang Vaccine Laboratories Co. Ltd., Hipra Corporations, VETVACO National Veterinary Joint Stock Company, Kyoto Biken Laboratories Inc., Fatro Spa

North America was the largest region in the ruminant vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ruminant vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ruminant vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ruminant vaccines market consists of sales of brucellosis vaccines, bluetongue virus vaccines, E. coli vaccines, mycoplasma vaccines, and chlamydia vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ruminant Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ruminant vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ruminant vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ruminant vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Vaccine Type: Inactivated Vaccines; Attenuated Or Modified Live Vaccines; Other Vaccine Types
• 2) By Indication: Bovine Respiratory Diseases (BRD); Diarrhea Or Scours; Foot-and-Mouth Disease (FMD); Clostridial Diseases; Leptospirosis; Bovine Viral Diarrhea (BVD) Infection; Other Indication
• 3) By Route Of Administration: Intramuscular; Subcutaneous; Intranasal; Oral
• 4) By Application: Cattle; Sheep; Other Applications
• 5) By End-User: Veterinary Hospitals And Clinics; Livestock Farms; Research Institutes
• Subsegments:
• 1) By Inactivated Vaccines: Killed Virus Vaccines; Bacterial Inactivated Vaccines; Subunit Vaccines
• 2) By Attenuated or Modified Live Vaccines: Live Attenuated Virus Vaccines; Live Bacterial Vaccines; Recombinant Live Vaccines
• 3) By Other Vaccine Types: DNA Vaccines; mRNA Vaccines; Viral Vector Vaccines
• Companies Mentioned: Boehringer Ingelheim International GmbH; Zoetis Inc.; Merck & Co. Inc.; Elanco Animal Health Inc.; Ceva Sante Animale
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ruminant Vaccines Market Characteristics

3. Ruminant Vaccines Market Trends And Strategies

4. Ruminant Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Ruminant Vaccines Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ruminant Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ruminant Vaccines Market Growth Rate Analysis
• 5.4. Global Ruminant Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ruminant Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ruminant Vaccines Total Addressable Market (TAM)

6. Ruminant Vaccines Market Segmentation

• 6.1. Global Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inactivated Vaccines
• Attenuated Or Modified Live Vaccines
• Other Vaccine Types
• 6.2. Global Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine Respiratory Diseases (BRD)
• Diarrhea Or Scours
• Foot-And-Mouth Disease (FMD)
• Clostridial Diseases
• Leptospirosis
• Bovine Viral Diarrhea (BVD) Infection
• Other Indication
• 6.3. Global Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intramuscular
• Subcutaneous
• Intranasal
• Oral
• 6.4. Global Ruminant Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cattle
• Sheep
• Other Applications
• 6.5. Global Ruminant Vaccines Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals And Clinics
• Livestock Farms
• Research Institutes
• 6.6. Global Ruminant Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Killed Virus Vaccines
• Bacterial Inactivated Vaccines
• Subunit Vaccines
• 6.7. Global Ruminant Vaccines Market, Sub-Segmentation Of Attenuated or Modified Live Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Live Attenuated Virus Vaccines
• Live Bacterial Vaccines
• Recombinant Live Vaccines
• 6.8. Global Ruminant Vaccines Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Vaccines
• mRNA Vaccines
• Viral Vector Vaccines

7. Ruminant Vaccines Market Regional And Country Analysis

• 7.1. Global Ruminant Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ruminant Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ruminant Vaccines Market

• 8.1. Asia-Pacific Ruminant Vaccines Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ruminant Vaccines Market

• 9.1. China Ruminant Vaccines Market Overview
• 9.2. China Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ruminant Vaccines Market

• 10.1. India Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ruminant Vaccines Market

• 11.1. Japan Ruminant Vaccines Market Overview
• 11.2. Japan Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ruminant Vaccines Market

• 12.1. Australia Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ruminant Vaccines Market

• 13.1. Indonesia Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ruminant Vaccines Market

• 14.1. South Korea Ruminant Vaccines Market Overview
• 14.2. South Korea Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ruminant Vaccines Market

• 15.1. Western Europe Ruminant Vaccines Market Overview
• 15.2. Western Europe Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ruminant Vaccines Market

• 16.1. UK Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ruminant Vaccines Market

• 17.1. Germany Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ruminant Vaccines Market

• 18.1. France Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ruminant Vaccines Market

• 19.1. Italy Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ruminant Vaccines Market

• 20.1. Spain Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ruminant Vaccines Market

• 21.1. Eastern Europe Ruminant Vaccines Market Overview
• 21.2. Eastern Europe Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ruminant Vaccines Market

• 22.1. Russia Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ruminant Vaccines Market

• 23.1. North America Ruminant Vaccines Market Overview
• 23.2. North America Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ruminant Vaccines Market

• 24.1. USA Ruminant Vaccines Market Overview
• 24.2. USA Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ruminant Vaccines Market

• 25.1. Canada Ruminant Vaccines Market Overview
• 25.2. Canada Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ruminant Vaccines Market

• 26.1. South America Ruminant Vaccines Market Overview
• 26.2. South America Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ruminant Vaccines Market

• 27.1. Brazil Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ruminant Vaccines Market

• 28.1. Middle East Ruminant Vaccines Market Overview
• 28.2. Middle East Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ruminant Vaccines Market

• 29.1. Africa Ruminant Vaccines Market Overview
• 29.2. Africa Ruminant Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ruminant Vaccines Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ruminant Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ruminant Vaccines Market Competitive Landscape And Company Profiles

• 30.1. Ruminant Vaccines Market Competitive Landscape
• 30.2. Ruminant Vaccines Market Company Profiles
  • 30.2.1. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Elanco Animal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

31. Ruminant Vaccines Market Other Major And Innovative Companies

• 31.1. Virbac
• 31.2. Phibro Animal Health Corporation
• 31.3. Vetoquinol S.A.
• 31.4. Indian Immunologicals Ltd.
• 31.5. Anicon Labor GmbH (SAN Group)
• 31.6. IDT Biologika GmbH
• 31.7. Jinyu Bio-Technology Co. Ltd.
• 31.8. Vaxxinova International B.V.
• 31.9. Biogenesis Bago S.A
• 31.10. CZ Vaccines
• 31.11. Hester Biosciences Limited
• 31.12. Choong Ang Vaccine Laboratories Co. Ltd.
• 31.13. Hipra Corporations
• 31.14. VETVACO National Veterinary Joint Stock Company
• 31.15. Kyoto Biken Laboratories Inc.

32. Global Ruminant Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ruminant Vaccines Market

34. Recent Developments In The Ruminant Vaccines Market

35. Ruminant Vaccines Market High Potential Countries, Segments and Strategies

• 35.1 Ruminant Vaccines Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ruminant Vaccines Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ruminant Vaccines Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33549_Ruminant_Vaccines_GMR_2025